AI assistant
Sending…
MANNATECH INC — Director's Dealing 2004
Mar 24, 2004
35056_dirs_2004-03-24_df05dd38-79b5-47e9-8b24-aeabc91d3c42.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MANNATECH INC (MTEX)
CIK: 0001056358
Period of Report: 2004-03-24
Reporting Person: MCANALLEY BILL H (Chief Science Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-03-18 | Common Stock acquired through exercise of stock option | X | 50000 | $2.63 | Acquired | 319082 | Direct |
| 2004-03-18 | Common stock acquired through exercise of stock option | X | 50000 | $2.69 | Acquired | 319082 | Direct |
| 2004-03-18 | Common stock acquired through exercise of stock option | X | 7021 | $8.00 | Acquired | 319082 | Direct |
| 2004-03-18 | Common stock surrendered to exercise stock options | J | 30566 | $10.54 | Disposed | 319082 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2004-03-18 | Exercise of common stock options | $2.63 | X | 50000 | Acquired | 2010-08-23 | Common stock, par value $0.0001 per share (50000) | Direct |
| 2004-03-18 | Exercise of common stock options | $2.69 | X | 50000 | Acquired | 2011-11-01 | Common stock, par value $0.0001 per share (50000) | Direct |
| 2004-03-18 | Exercise of common stock options | $8.00 | X | 7021 | Acquired | 2008-11-25 | Common stock, par value $0.0001 per share (7021) | Direct |
Footnotes
F1: Dr. McAnalley tendered 30,566 of his common stock to Mannatech in exchange to exercise 50,000 stock options at $2.63, 50,000 stock options at $2.69 and 7,021 stock options at $8.00.
More from MANNATECH INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
Apr 21
Regulatory Filings
2026
Apr 15
Annual Report
2026
Apr 15
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6